nd.gov - The Official Portal for North Dakota State Government
North Dakota: Legendary. Follow the trail of legends
NDDHS logo Mother and daughter graphic
 arrowDHS Home arrowContact DHS arrowSkip Navigation
Search:

Medicaid Provider Information

Pharmacy Provider Drug Utilization Review Board

Per federal law, each state must establish a Drug Use Review (DUR) Board. North Dakota Medicaid's DUR Board has been active for many years. The DUR Board's functions include but are not limited to serving as an advisory board for various policies, identifying and developing educational topics for practitioners to improve drug therapy, and assisting the department in identifying patterns of fraud, abuse, gross overuse, or inappropriate or medically unnecessary care.

The DUR Board includes six physicians, six pharmacists, and three non-voting members as outlined by State Law and Administrative Rules. Meetings are held at least quarterly, and the meetings are open to the public. If you have any questions regarding N.D. Medicaid's DUR Board or the Medication Prior Authorization Program, please contact Brendan Joyce, PharmD, Administrator, Pharmacy Services at bjoyce@nd.gov.

DUR Board members serve staggered three year terms with a maximum of three renewals as described in state law. Below is a table showing the current schedule of the staggered terms and the board members serving those terms. All terms begin July 1 and end June 30 of the specified years. The Position column shows the member subset as well as the entity that appointed that member (e.g. RPh DHS 1 is one of two pharmacists appointed by the Department of Human Services). The number of remaining renewals (if applicable) are shown, and the Appointment Ends column is populated with the year the member would end service on the Board if they exhaust all available renewals.

Position Member Name Member Type Appointed Date Renewals Left Appointment Ends
Ex-Officio Betting, Gary, MD MD
N/A
N/A
OPEN
Ex-Officio Joyce, Brendan, PharmD Pharm
N/A
N/A
OPEN
Gov Appt McCleary, Carlotta Cons. Int.
7/1/2006
1
2018
GPhA Carlson, James, PharmD GPhA
9/1/2009
2
2021
MD DHS 1 Schield, Laura, MD MD
7/1/2014
3
2024
MD DHS 2 Woodrow, Peter, MD MD
7/1/2013
3
2025
MD NDMA 1 Booth, Michael, MD MD
12/1/2012
3
2024
MD NDMA 2 Hostetter, Jeffrey, MD MD
9/1/2007
1
2019
MD NDMA 3 Quast, Michael, MD MD
7/1/2014
3
2026
MD NDMA 4 Kavlie, Gaylord, MD MD
2/25/2016
3
2026
PhRMA Sobotta, Russ, PhRMA PhRMA
7/1/2009
2
2021
RPh DHS 1 Honeyman, Andrea PharmD
8/19/2015
3
2027
RPh DHS 2 Kram, Katie, PharmD Pharm
7/1/2014
3
2026
RPh NDPhA 1 Marty, Zach, PharmD Pharm
3/3/2016
3
2025
RPh NDPhA 2 Roehrich, LeNeika, PharmD Pharm
9/4/2015
3
2027
RPh NDPhA 3 Schmidt, Tanya, PharmD Pharm
4/1/2012
2
2022
RPh NDPhA 4 Brown, Wendy, PharmD Pharm
7/1/2014
3
2026

 

 

Return to the top of the page Top of page   Go back to the previous page Back to previous page


 Get Adobe Acrobat Reader Tested for W3C WAI AA Accessibility Tested for W3C Well-Formed XHTML Code Tested for W3C Well Formed Cascading Style Sheet Code